Sirtuins in cognitive ageing and Alzheimer's disease

Current Opinion in Psychiatry

Volumn 25, Issue 3, 2012, Pages 226-230

  Braidy, Nady ^a,b   Jayasena, Tharusha ^a   Poljak, Anne ^b,c   Sachdev, Perminder S ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

ageing; Alzheimer's disease; amyloid; calorie restriction; sirtuins

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID; AMYLOID BETA PROTEIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDASE; NOTCH RECEPTOR; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN 1; TAU PROTEIN; TRANSCRIPTION FACTOR FKHR;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CALORIC RESTRICTION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; LONGEVITY; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

AGING; ALZHEIMER DISEASE; CALORIC RESTRICTION; COGNITION; COGNITION DISORDERS; HUMANS; LONGEVITY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; SIRTUIN 1; SIRTUINS;

EID: 84859429591     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32835112c1     Document Type: Review

References (37)

1. Harman D. Ageing: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
2. Guarente L. Mitochondria: a nexus for ageing, calorie restriction and sirtuins? Cell 2008; 132:171-176. (Pubitemid 351172441)
3. Braidy N, Guillemin G, Grant R. Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease. Neurotox Res 2008; 13:173-184.
4. Bonda DJ, Wang X, Perry G, et al. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010; 59:290-294.
5. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1:120-129.
6. Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon 2010; 56:484-546.
7. Yassa MA, Muftuler LT, Stark CE. Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo. Proc Natl Acad Sci U S A 2010; 107:12687-12691.
8. Masoro EJ. Caloric restriction and ageing: an update. Exp Gerontol 2000; 35:299-305.
9. Koubova J, Guarente L. How does calorie restriction work? Genes Dev 2003; 17:313-321. (Pubitemid 36182188)
10. Sinclair DA. Paradigms and pitfalls of yeast longevity research. Mech Ageing Dev 2002; 123:857-867. (Pubitemid 34603069)
11. Song JH, Yu JT, Liu M, et al. Genetic association between ADAM10 gene polymorphismand Alzheimer's disease in a Northern Han Chinese population. Brain Res 2011; 1421:78-81.
12. Albani D, Polito L, Forloni G. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 2010; 19:11-26.
13. Elliott PJ, Jirousek M. Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs 2008; 9:371-378. (Pubitemid 351507663)
14. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303:2011-2015. (Pubitemid 38393275)
15. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23:2369-2380. (Pubitemid 38954844)
16. Langley E, Pearson M, Faretta M, et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002; 21:2383-2396. (Pubitemid 34546711)
17. Wang J, Fivecoat H, Ho L, et al. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology. Biochim Biophys Acta 2010; 1804:1690-1694.
18. Braidy N, Guillemin G, Mansour H, et al. Age related changes in NAD+ metabolism, oxidative stress and Sirt1 activity in wistar rats. PLoS One 2011; 6:e19194.
19. Xiong S, Salazar G, Patrushev N, et al. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J Biol Chem 2011; 286:5289-5299.
20. Yuan F, Xie Q, Wu J, et al. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation. J Biol Chem 2011; 286:6940-6945.
21. Bordone L, Cohen D, Robinson A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Ageing Cell 2007; 6:759-767. (Pubitemid 350131044)
22. Michán S, Li Y, Chou MM, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010; 30:9695-9707.
23. Chung S, Yao H, Caito S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010; 501:79-90.
24. Albani D, Polito L, Batelli S, et al. The SIRT1 activator resveratrol protects SKN-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 2009; 110:1445-1456.
25. Qin W, Yang T, Ho L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006; 281:21745-21754. (Pubitemid 44181878)
26. Heneka MT, O'Banion MK, Terwel D, et al. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 2010; 117:919-947.
27. Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microgliadependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005; 280:40364-40374. (Pubitemid 41779174)
28. Donmez G, Wang D, Cohen DE, et al. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010; 142:320-332.
29. Greco SJ, Hamzelou A, Johnston JM, et al. Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and b-amyloid in neurons. Biochem Biophys Res Commun 2011; 414:170-174.
30. Cruz JC, Tseng HC, Goldman JA, et al. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003; 40:471-483. (Pubitemid 37494698)
31. Vlassenko AG, Vaishnavi SN, Couture L, et al. Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci U S A 2010; 107:17763-17767.
32. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-1033.
33. Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134:329-340. (Pubitemid 352010336)
34. Zhang Q, Wang SY, Fleuriel C, et al. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A 2007; 104:829-833. (Pubitemid 46154696)
35. Guo W, Qian L, Zhang J, et al. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res 2011; 89:1723-1736.
36. Chae HD, Broxmeyer HE. SIRT1 deficiency downregulates PTEN/JNK/ FOXO1 pathway to block ROS-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev 2011; 20:1277-1285.
37. Huang PS, Son JH, Abbott LC, et al. Regulated expression of neuronal SIRT1 and related genes by ageing and neuronal b2-containing nicotinic cholinergic receptors. Neuroscience 2011; 196:189-202.